Mind Medicine (MindMed) Balance Sheet Health
Financial Health criteria checks 5/6
Mind Medicine (MindMed) has a total shareholder equity of $78.1M and total debt of $14.1M, which brings its debt-to-equity ratio to 18.1%. Its total assets and total liabilities are $124.5M and $46.4M respectively.
Key information
18.1%
Debt to equity ratio
US$14.13m
Debt
| Interest coverage ratio | n/a |
| Cash | US$99.70m |
| Equity | US$78.13m |
| Total liabilities | US$46.41m |
| Total assets | US$124.54m |
Recent financial health updates
Mind Medicine (MindMed) (NASDAQ:MNMD) Is In A Good Position To Deliver On Growth Plans
May 23
We're Hopeful That Mind Medicine (MindMed) (NASDAQ:MNMD) Will Use Its Cash Wisely
Feb 07Mind Medicine (MindMed) (NASDAQ:MNMD) Is In A Good Position To Deliver On Growth Plans
Aug 26Recent updates
Mind Medicine: GAD Program Success Continues With BTD And Positive Treatment Data
Apr 04Mind Medicine: Positive MM-120 Data Leads To Other 2024 Catalysts
Feb 02Mind Medicine (MindMed) (NASDAQ:MNMD) Is In A Good Position To Deliver On Growth Plans
May 23We're Hopeful That Mind Medicine (MindMed) (NASDAQ:MNMD) Will Use Its Cash Wisely
Feb 07MindMed: Not The Horse To Back If You're Looking To Buy Psychedelics
Oct 19MindMed announces proposed public offering of common shares
Sep 27MindMed doses first patient in phase 1 trial examining psychedelic MDMA-like substances
Sep 20MindMed regains compliance with Nasdaq's minimum bid price listing requirement
Sep 14MindMed: Confusing MEME Rally Hides A Company That Looks Empty Of Value
Sep 04Mind Medicine (MindMed) (NASDAQ:MNMD) Is In A Good Position To Deliver On Growth Plans
Aug 26Magic mushrooms psychedelic compound can help with treatment of alcohol use disorder
Aug 24MindMed soars 71% as it appears to be following in Bed Bath & Beyond's footsteps
Aug 18Mind Medicine GAAP EPS of -$0.04 beats by $0.01
Aug 11Mind Medicine announces 1-for-15 reverse stock split
Aug 04MindMed: Another Psychedelic Medicine Play Trading At A Potential Discount
Jul 12Mind Medicine: It's Best To Stay Far Away From This Risky Psychedelic Stock
Apr 20MindMed: Falling Uncontrollably
Jan 27Financial Position Analysis
Short Term Liabilities: MNMD's short term assets ($103.9M) exceed its short term liabilities ($32.2M).
Long Term Liabilities: MNMD's short term assets ($103.9M) exceed its long term liabilities ($14.2M).
Debt to Equity History and Analysis
Debt Level: MNMD has more cash than its total debt.
Reducing Debt: Insufficient data to determine if MNMD's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MNMD has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: MNMD has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 29.9% each year.